AT
ZBH icon

Arden Trust’s Zimmer Biomet ZBH Stock Holding History

Arden Trust’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-6,676
Closed -$780 – 514
2016
Q2 		$780 Sell
6,676
-66
-1% -$7.47K 0.06% 289
2016
Q1 		$698K Buy
6,742
+344
+5% +$33.3K 0.06% 311
2015
Q4 		$637K Buy
6,398
+384
+6% +$37.6K 0.05% 328
2015
Q3 		$548K Buy
+6,014
New +$603K 0.05% 376

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Arden Trust's ZBH Position: Q3 2016 in Review

Arden Trust sold out of Zimmer Biomet (ZBH) in Q3 2016, closing a stake of 6,676 shares — an estimated $780 sold.

Arden Trust first reported a position in ZBH in Q3 2015 and held it in 4 quarters. The position peaked at $698K in Q1 2016. 808 funds tracked by Wall St. Rank hold ZBH as of Q3 2016.

  • Arden Trust reported no remaining Zimmer Biomet position as of Q3 2016 after selling out during the quarter.
  • Arden Trust sold 6,676 Zimmer Biomet shares in Q3 2016, an estimated $780.
  • Arden Trust first reported a position in Zimmer Biomet in Q3 2015 and held it in 4 quarters.
  • Arden Trust's Zimmer Biomet position peaked at $698K in Q1 2016.
  • 808 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2016.

Based on Arden Trust's 13F filing for Q3 2016, filed 14 Oct 2016.